158 related articles for article (PubMed ID: 33264551)
1. Prostate Cancer Progression and the Epigenome.
Arap W; Pasqualini R; Costello JF
N Engl J Med; 2020 Dec; 383(23):2287-2290. PubMed ID: 33264551
[No Abstract] [Full Text] [Related]
2. Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Pomerantz MM; Qiu X; Zhu Y; Takeda DY; Pan W; Baca SC; Gusev A; Korthauer KD; Severson TM; Ha G; Viswanathan SR; Seo JH; Nguyen HM; Zhang B; Pasaniuc B; Giambartolomei C; Alaiwi SA; Bell CA; O'Connor EP; Chabot MS; Stillman DR; Lis R; Font-Tello A; Li L; Cejas P; Bergman AM; Sanders J; van der Poel HG; Gayther SA; Lawrenson K; Fonseca MAS; Reddy J; Corona RI; Martovetsky G; Egan B; Choueiri T; Ellis L; Garraway IP; Lee GM; Corey E; Long HW; Zwart W; Freedman ML
Nat Genet; 2020 Aug; 52(8):790-799. PubMed ID: 32690948
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Ratliff TL
J Urol; 2005 Sep; 174(3):1149. PubMed ID: 16094083
[No Abstract] [Full Text] [Related]
4. [The mechanisms of prostate cancer progression through androgen receptor].
Goto Y; Sakamoto S; Ichikawa T
Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
6. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Fernandes RC; Hickey TE; Tilley WD; Selth LA
Endocr Relat Cancer; 2019 May; 26(5):R237-R257. PubMed ID: 30817318
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.
Zhao J; Zhang Y; Liu XS; Zhu FM; Xie F; Jiang CY; Zhang ZY; Gao YL; Wang YC; Li B; Xia SJ; Han BM
Cancer Sci; 2020 Feb; 111(2):369-382. PubMed ID: 31833612
[TBL] [Abstract][Full Text] [Related]
10. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
11. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
[TBL] [Abstract][Full Text] [Related]
12. Functional Silencing of
Gao X; Dai C; Huang S; Tang J; Chen G; Li J; Zhu Z; Zhu X; Zhou S; Gao Y; Hou Z; Fang Z; Xu C; Wang J; Wu D; Sharifi N; Li Z
Clin Cancer Res; 2019 Feb; 25(4):1291-1301. PubMed ID: 30228209
[TBL] [Abstract][Full Text] [Related]
13. Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression.
Dryhurst D; McMullen B; Fazli L; Rennie PS; Ausió J
Cancer Lett; 2012 Feb; 315(1):38-47. PubMed ID: 22055461
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
16. Amplification and co-regulators of androgen receptor gene in prostate cancer.
Golias Ch; Iliadis I; Peschos D; Charalabopoulos K
Exp Oncol; 2009 Mar; 31(1):3-8. PubMed ID: 19300409
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor functions in prostate cancer development and progression.
Balk SP
Asian J Androl; 2014; 16(4):561-4. PubMed ID: 24759584
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptors in early and castration resistant prostate cancer: friend or foe?
Pelekanou V; Notas G; Stathopoulos EN; Castanas E; Kampa M
Hormones (Athens); 2013; 12(2):224-35. PubMed ID: 23933691
[No Abstract] [Full Text] [Related]
20. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]